Cite
HARVARD Citation
Tawbi, H. et al. (2021). Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study. Lancet oncology. 22 (12), pp. 1692-1704. [Online].